Goldenrod Therapeutics, Inc.
PrivateLast Round
Seed
Jun 3, 2026
Total Funding Raised
$920,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Goldenrod Therapeutics, Inc. is a biotechnology company developing next-generation, brain-penetrant phosphodiesterase 4 (PDE4) inhibitors for serious neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Goldenrod Therapeutics, Inc. Comparables
Compare Goldenrod Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enthorin Therapeutics | 83% | |
| Shionogi & Co. | 74% | |
| PTC Therapeutics Inc | 69% | |
Goldenrod Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 3, 2026 | ||||
| Grant | Nov 5, 2024 | ||||
| Grant | Oct 10, 2024 | ||||
| Grant | Jul 14, 2021 |
Goldenrod Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| Fannin Innovation Studio | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2026
$3.2M seed round completed.
Goldenrod Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Goldenrod Therapeutics, Inc.'s valuation, stock price, and market status.